FALLS CHURCH, Va. — Response Pharmaceuticals reported positive 36-week Phase 2 data supporting its investigational therapy RDX-002 as a potential long-term option for maintaining...
CAMBRIDGE, Mass. — Parabilis Medicines reported preliminary clinical evidence that its investigational drug zolucatetide may reduce polyp burden in patients with familial adenomatous polyposis...
SOUTH SAN FRANCISCO, Calif. — Thermo Fisher Scientific has opened a new Cryo-Electron Microscopy (cryo-EM) Drug Discovery Center in South San Francisco, providing pharmaceutical...
CAMBRIDGE, Mass. — Researchers, patient advocates, biotechnology executives, and state policymakers will gather on Wednesday, February 25, 2026, from 10:00 a.m. to 2:00 p.m....
WALTHAM, Mass. — Trinity has been ranked among the world’s leading health sciences consulting firms in the 2026 Vault Consulting Rankings, earning recognition in...
CAMBRIDGE, Mass. — Prime Coalition and Rho Impact said they have expanded their partnership to provide free access to investor-grade climate impact data, making...
ORANGE, Conn. — The Avangrid Foundation announced that it has awarded $250,000 in grant funding to 13 wildlife rehabilitation centers across the United States...
PALO ALTO, Calif. — Frazier Life Sciences, an investment firm focused on innovative therapeutics, has appointed Charles (Charlie) Fuchs, M.D., M.P.H., as Senior Advisor.
Dr....
BOSTON, Mass. — Commercial property owners seeking new sources of revenue without committing capital may find an opportunity directly overhead. Solect Energy has published...
Recent Comments